Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia

BACKGROUND: Between December 2018 and January of 2019, we evaluated the accuracy of the point-of-care Hepatitis C (HCV) antibody test (POC; OraQuick HCV) used at a community-based needle and syringe exchange program serving persons who inject drugs in Tallinn, Estonia. METHODS: We compared the resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Uusküla, Anneli, Talu, Ave, Rannap, Jürgen, Barnes, David M., Jarlais, Don Des
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015736/
https://www.ncbi.nlm.nih.gov/pubmed/33794927
http://dx.doi.org/10.1186/s12954-021-00485-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015736/
https://www.ncbi.nlm.nih.gov/pubmed/33794927
http://dx.doi.org/10.1186/s12954-021-00485-5

Ejemplares similares